PL2655595T3 - Nowa bakteria i ekstrakty ze wspomnianej bakterii oraz ich zastosowanie w dermatologii - Google Patents

Nowa bakteria i ekstrakty ze wspomnianej bakterii oraz ich zastosowanie w dermatologii

Info

Publication number: PL2655595T3
Authority: PL; Poland
Prior art keywords: bacterium; dermatology; extracts; same; novel
Prior art date: 2010-12-22

Application number

PL11802426T

Other languages

English (en)

Inventor

Philippe Lebaron

Muriel BOURRAIN

Nathalie Castex-Rizzi

Thien Nguyen

Bertrand Chol

Marie-Françoise ARIES

Katia RAVARD HELFFER

Original Assignee

Pierre Fabre Dermo-Cosmétique

Sorbonne Université

Centre National De La Recherche Scientifique (Cnrs)

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-12-22

Filing date

2011-12-22

Publication date

2019-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44359781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2655595(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-12-22 Application filed by Pierre Fabre Dermo-Cosmétique, Sorbonne Université, Centre National De La Recherche Scientifique (Cnrs) filed Critical Pierre Fabre Dermo-Cosmétique

2019-07-31 Publication of PL2655595T3 publication Critical patent/PL2655595T3/pl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/36—Neisseria

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Cosmetics (AREA)
Birds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

PL11802426T 2010-12-22 2011-12-22 Nowa bakteria i ekstrakty ze wspomnianej bakterii oraz ich zastosowanie w dermatologii PL2655595T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR1061081A FR2969657B1 (fr)	2010-12-22	2010-12-22	Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
EP11802426.4A EP2655595B1 (en)	2010-12-22	2011-12-22	Novel bacterium and extracts of said bacterium and the use of same in dermatology
PCT/EP2011/073747 WO2012085182A1 (en)	2010-12-22	2011-12-22	Novel bacterium and extracts of said bacterium and the use of same in dermatology

Publications (1)

Publication Number	Publication Date
PL2655595T3 true PL2655595T3 (pl)	2019-07-31

Family

ID=44359781

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL11802426T PL2655595T3 (pl)	2010-12-22	2011-12-22	Nowa bakteria i ekstrakty ze wspomnianej bakterii oraz ich zastosowanie w dermatologii

Country Status (29)

Country	Link
US (2)	US9084811B2 (pl)
EP (1)	EP2655595B1 (pl)
JP (2)	JP6117111B2 (pl)
KR (1)	KR102043472B1 (pl)
CN (1)	CN103403144B (pl)
AR (1)	AR084454A1 (pl)
AU (1)	AU2011347254B2 (pl)
CA (1)	CA2821653C (pl)
CL (1)	CL2013001853A1 (pl)
CO (1)	CO6741177A2 (pl)
DK (1)	DK2655595T3 (pl)
ES (1)	ES2689138T3 (pl)
FR (1)	FR2969657B1 (pl)
GE (1)	GEP201606589B (pl)
IL (1)	IL226943B (pl)
MA (1)	MA34734B1 (pl)
MX (1)	MX345125B (pl)
MY (1)	MY173066A (pl)
NZ (1)	NZ612294A (pl)
PH (1)	PH12013501267A1 (pl)
PL (1)	PL2655595T3 (pl)
PT (1)	PT2655595T (pl)
RU (1)	RU2612790C2 (pl)
SG (1)	SG191236A1 (pl)
TN (1)	TN2013000249A1 (pl)
TW (1)	TW201307551A (pl)
UA (1)	UA113399C2 (pl)
WO (1)	WO2012085182A1 (pl)
ZA (1)	ZA201304355B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013190106A1 (en) *	2012-06-21	2013-12-27	Pierre Fabre Medicament	Use of a live bacterium for the treatment of intestinal inflammatory disorders
AU2014326596B2 (en)	2013-09-25	2018-12-13	Vertex Pharmaceuticals Incorporated	Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway
FR3065009B1 (fr)	2017-04-06	2020-11-27	Fabre Pierre Dermo Cosmetique	Secretome bacterien pour son utilisation dans le traitement des lesions cutanees
FR3081705B1 (fr)	2018-06-01	2020-12-04	Fabre Pierre Dermo Cosmetique	Extrait et composition dermatologique le comprenant pour le traitement des peaux sensibles
FR3114024B1 (fr)	2020-09-11	2022-09-09	Fabre Pierre Dermo Cosmetique	Nouvelle émulsion mimant la peau
JP7695824B2 (ja) *	2021-06-02	2025-06-19	花王株式会社	皮膚細菌感染症の予防又は改善剤
JP7698983B2 (ja) *	2021-06-02	2025-06-26	花王株式会社	腸管感染症の予防又は改善剤
KR20260003714A (ko) *	2023-04-18	2026-01-07	삐에르화브르데르모-코스메띠끄	피부 염증 치료에 유용한 신규 세균 균주
FR3150712A1 (fr)	2023-07-06	2025-01-10	Pierre Fabre Dermo-Cosmetique	Composition pour le traitement de désordres inflammatoires cutanés
FR3149774B1 (fr)	2024-01-11	2025-06-20	Fabre Pierre Dermo Cosmetique	5,6,5’,6’-tétraphényl-3,3’-(1,4-phénylène)-bis[1,2,4]triazine pour améliorer l’aspect des cicatrices et/ou réduire les marques cicatricielles

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE123417T1 (de) *	1989-10-06	1995-06-15	Janos Szabo	Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen, insbesondere pyogener und atopischer dermatitis und verfahren zu deren herstellung.
CH680045A5 (pl) *	1990-02-16	1992-06-15	Om Lab Sa
EP0761204B1 (fr) *	1995-09-07	1998-04-15	L'oreal	Utilisation d'un extrait d'une bactérie filamenteuse non photosynthétique et composition le contenant
AU2003239125A1 (en) *	2002-03-20	2003-10-08	Emory University	Neisseria mutants, lipooligosaccharides and immunogenic compositions
GB0321615D0 (en) *	2003-09-15	2003-10-15	Glaxo Group Ltd	Improvements in vaccination
US20050163764A1 (en) *	2003-09-22	2005-07-28	Yale University	Treatment with agonists of toll-like receptors
US7244607B2 (en) *	2003-10-01	2007-07-17	The United States Of America, As Represented By The Secretary Of Agriculture	Chromobacterium subtsugae sp. nov. for control of insect pests
PL2114421T3 (pl) *	2007-03-05	2018-07-31	Om Pharma	Ekstrakt bakteryjny do stosowania względem zaburzeń oddechowych i sposób jego wytwarzania
FR2918883B1 (fr) *	2007-07-17	2010-01-15	Oreal	Utilisation d'un extrait bacterien cultive sur une eau thermale pour le traitement des peaux seches
FR2918884B1 (fr) *	2007-07-17	2010-01-15	Oreal	Utilisation d'extraits bacteriens cultives sur eau thermale comme agent anti-rougeur
FR2918885B1 (fr) *	2007-07-17	2009-08-28	Oreal	Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires
JP2011519834A (ja)	2008-04-25	2011-07-14	インスティチュートフォーシステムズバイオロジー	フラジェリンポリペプチドワクチン
WO2009132244A1 (en) *	2008-04-25	2009-10-29	Id Biomedical Corporation Of Quebec	Methods for preparing immunogenic compositions
SI22889A (sl)	2008-10-28	2010-04-30	Kemijski inštitut	Himerni flagelini za cepiva
WO2010135704A2 (en)	2009-05-22	2010-11-25	Institute For Systems Biology	Secretion-related bacterial proteins for nlrc4 stimulation
KR101762610B1 (ko) *	2010-11-05	2017-08-04	삼성전자주식회사	이동 통신 시스템에서 역방향 스케줄링 및 그를 위한 정보 전송 방법 및 장치

2010
- 2010-12-22 FR FR1061081A patent/FR2969657B1/fr active Active
2011
- 2011-12-21 AR ARP110104841A patent/AR084454A1/es active IP Right Grant
- 2011-12-21 TW TW100147712A patent/TW201307551A/zh unknown
- 2011-12-22 SG SG2013047055A patent/SG191236A1/en unknown
- 2011-12-22 ES ES11802426.4T patent/ES2689138T3/es active Active
- 2011-12-22 PH PH1/2013/501267A patent/PH12013501267A1/en unknown
- 2011-12-22 WO PCT/EP2011/073747 patent/WO2012085182A1/en not_active Ceased
- 2011-12-22 CA CA2821653A patent/CA2821653C/en active Active
- 2011-12-22 EP EP11802426.4A patent/EP2655595B1/en active Active
- 2011-12-22 NZ NZ612294A patent/NZ612294A/en unknown
- 2011-12-22 GE GEAP201113131A patent/GEP201606589B/en unknown
- 2011-12-22 DK DK11802426.4T patent/DK2655595T3/en active
- 2011-12-22 UA UAA201309001A patent/UA113399C2/uk unknown
- 2011-12-22 MY MYPI2013002355A patent/MY173066A/en unknown
- 2011-12-22 RU RU2013132895A patent/RU2612790C2/ru active
- 2011-12-22 US US13/997,029 patent/US9084811B2/en active Active
- 2011-12-22 CN CN201180062363.2A patent/CN103403144B/zh active Active
- 2011-12-22 JP JP2013545395A patent/JP6117111B2/ja active Active
- 2011-12-22 MX MX2013007217A patent/MX345125B/es active IP Right Grant
- 2011-12-22 AU AU2011347254A patent/AU2011347254B2/en active Active
- 2011-12-22 PL PL11802426T patent/PL2655595T3/pl unknown
- 2011-12-22 PT PT11802426T patent/PT2655595T/pt unknown
- 2011-12-22 KR KR1020137016743A patent/KR102043472B1/ko active Active
2013
- 2013-06-10 TN TNP2013000249A patent/TN2013000249A1/fr unknown
- 2013-06-13 ZA ZA2013/04355A patent/ZA201304355B/en unknown
- 2013-06-13 MA MA36009A patent/MA34734B1/fr unknown
- 2013-06-13 IL IL226943A patent/IL226943B/en active IP Right Grant
- 2013-06-17 CO CO13144310A patent/CO6741177A2/es unknown
- 2013-06-21 CL CL2013001853A patent/CL2013001853A1/es unknown
2015
- 2015-02-19 US US14/626,589 patent/US9662357B2/en active Active
2017
- 2017-01-12 JP JP2017003631A patent/JP2017099393A/ja active Pending

Also Published As

Publication number	Publication date
FR2969657B1 (fr)	2014-02-07
JP6117111B2 (ja)	2017-04-19
CA2821653C (en)	2020-03-10
AU2011347254A1 (en)	2013-07-11
CL2013001853A1 (es)	2014-03-28
JP2017099393A (ja)	2017-06-08
WO2012085182A1 (en)	2012-06-28
GEP201606589B (en)	2017-01-10
DK2655595T3 (en)	2018-10-08
NZ612294A (en)	2015-05-29
BR112013015998A2 (pt)	2017-04-11
RU2013132895A (ru)	2015-01-27
SG191236A1 (en)	2013-07-31
US20150231187A1 (en)	2015-08-20
IL226943B (en)	2019-02-28
MX345125B (es)	2017-01-17
AR084454A1 (es)	2013-05-15
JP2014503211A (ja)	2014-02-13
CN103403144A (zh)	2013-11-20
CN103403144B (zh)	2015-11-25
TW201307551A (zh)	2013-02-16
TN2013000249A1 (en)	2014-11-10
US9662357B2 (en)	2017-05-30
AU2011347254B2 (en)	2016-07-14
UA113399C2 (xx)	2017-01-25
KR20140030109A (ko)	2014-03-11
PT2655595T (pt)	2018-11-02
ES2689138T3 (es)	2018-11-08
MA34734B1 (fr)	2013-12-03
CO6741177A2 (es)	2013-08-30
EP2655595B1 (en)	2018-07-04
KR102043472B1 (ko)	2019-11-11
CA2821653A1 (en)	2012-06-28
MY173066A (en)	2019-12-23
RU2612790C2 (ru)	2017-03-13
FR2969657A1 (fr)	2012-06-29
HK1187366A1 (zh)	2014-04-04
EP2655595A1 (en)	2013-10-30
ZA201304355B (en)	2014-11-26
PH12013501267A1 (en)	2013-08-28
MX2013007217A (es)	2014-01-08
US9084811B2 (en)	2015-07-21
US20130316033A1 (en)	2013-11-28

Publication	Publication Date	Title
PT2655595T (pt)	2018-11-02	Bactéria e extratos da referida bactéria e uso dos mesmos em dermatologia
IL249669B (en)	2020-05-31	Converted 5-fluoro-h1-pyrazolopyridines and their use
IL221511A (en)	2015-04-30	Arilatriazolones associated with bis aryl and their use
SI2606120T1 (sl)	2016-03-31	Človeške facilitacijske celice in njihova uporaba
ZA201208173B (en)	2013-07-31	Peptices and their use
PT3210592T (pt)	2019-11-05	Sílica e composição de dentífrico compreendendo a mesma
ZA201305076B (en)	2014-12-23	Substituted 1-benzylccloalkycarboxlic acids and use thereof
PL2469142T3 (pl)	2015-12-31	Złączka zaciskowa i jej zastosowanie
PL2652025T3 (pl)	2018-12-31	Kompozycja powlekająca i jej zastosowanie
PL2605757T3 (pl)	2015-12-31	Preparaty oparte na nalbufinie i ich zastosowania
GB2480515B (en)	2016-12-28	Lacquer composition and use thereof
EP2697378A4 (en)	2014-10-01	IDENTIFICATION AND USE OF KRP MUTANTS IN PLANTS
PT2521445T (pt)	2019-12-05	Formulação e utilização da mesma
ZA201302854B (en)	2014-07-25	Substituted benzamides and their uses
PL2552440T3 (pl)	2019-04-30	Nowa kombinacja i zastosowanie
EP2638886A4 (en)	2017-04-26	Head-cooling pillow and head-cooling device
PT2563806E (pt)	2015-10-09	Leucolectinas humanas e suas utilizações
ZA201302335B (en)	2015-11-25	Susbtituted n-phenethyltriazoloneacetamides and use thereof
ZA201304460B (en)	2014-02-26	Novel bacterium and extracts of said bacterium and the use of same in therapy
GB201006479D0 (en)	2010-06-02	Garment and use thereof
IL217137A0 (en)	2012-02-29	Medicinal and herbal composition and uses thereof
EP2616088A4 (en)	2013-07-31	FUNGAL EXTRACTS AND USES THEREOF
AU2009902835A0 (en)	2009-07-09	Cosmetic methods and devices
AU2010904801A0 (en)	2010-11-11	Seleno-Compounds and Therapeutic Uses Thereof
GB201020268D0 (en)	2011-01-12	Composition and uses